Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer

Download this slideset with key data on optimal adjuvant therapy and extended adjuvant therapy for patients with early-stage HER2-positive breast cancer. Experts discuss how to identify which patients are most likely to benefit from the available treatment strategies.

Share

Program Content

Activities

Current Treatment Options for HER2+ EBC
Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer: Aligning Practice With Expert Consensus
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2019

Expires: April 23, 2020

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Puma Biotechnology, Inc.